Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medifast (MED) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Medifast (MED) over the last 15 years, with Q4 2025 value amounting to 0.07%.

  • Medifast's Return on Capital Employed fell 800.0% to 0.07% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.07%, marking a year-over-year decrease of 800.0%. This contributed to the annual value of 0.06% for FY2025, which is 800.0% down from last year.
  • According to the latest figures from Q4 2025, Medifast's Return on Capital Employed is 0.07%, which was down 800.0% from 0.03% recorded in Q3 2025.
  • Medifast's Return on Capital Employed's 5-year high stood at 1.11% during Q3 2022, with a 5-year trough of 0.07% in Q4 2025.
  • Over the past 5 years, Medifast's median Return on Capital Employed value was 0.78% (recorded in 2023), while the average stood at 0.59%.
  • As far as peak fluctuations go, Medifast's Return on Capital Employed soared by 2700bps in 2021, and later tumbled by -6900bps in 2024.
  • Medifast's Return on Capital Employed (Quarter) stood at 1.01% in 2021, then rose by 2bps to 1.02% in 2022, then crashed by -45bps to 0.57% in 2023, then crashed by -98bps to 0.01% in 2024, then tumbled by -613bps to 0.07% in 2025.
  • Its Return on Capital Employed was 0.07% in Q4 2025, compared to 0.03% in Q3 2025 and 0.0% in Q2 2025.